Zofran Linked to Birth Defects
Zofran was approved by the FDA more than 20 years ago to prevent nausea and vomiting in chemotherapy and surgery patients. It then became popular to prescribe Zofran for pregnant women to treat morning sickness. However, the FDA never approved the drug for use in pregnant women.
Recent studies have linked Zofran use during the first trimester of pregnancy to the development of congenital heart defects and oral clefts (cleft lip and palate). If you or a loved one took Zofran while pregnant and had a child born with cleft palate or heart defects, contact Diamond Massong to discuss your legal rights.
For more information or to schedule an appointment, please contact us for a free consultation.